The Impact of COVID-19 is included in Iron Deficiency Anemia Therapy Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Iron Deficiency Anemia Therapy Trends and Forecast
The future of the global iron deficiency anemia therapy market looks promising with opportunities in the hospital, clinic, and home healthcare markets. The global iron deficiency anemia therapy market is expected to reach an estimated $4.6 billion by 2030 with a CAGR of 5.3% from 2024 to 2030. The major drivers for this market are high incidence of iron deficiency anemia is attributed to insufficient iron intake from food and excessive loss of red blood cells, particularly affecting women and children, surge in female population, and growing awareness towards women health.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Iron Deficiency Anemia Therapy by Segment
The study includes a forecast for the global iron deficiency anemia therapy by therapy type, end use, and region.
Iron Deficiency Anemia Therapy Market by Therapy Type [Shipment Analysis by Value from 2018 to 2030]:
• Oral Iron Therapy
• Parenteral Iron Therapy
• Red Blood Cell Transfusion
Iron Deficiency Anemia Therapy Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Clinics
• Home Healthcare
Iron Deficiency Anemia Therapy Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Iron Deficiency Anemia Therapy Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies iron deficiency anemia therapy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the iron deficiency anemia therapy companies profiled in this report include-
• Abbvie
• Akebia Therapeutics
• AMAG Pharmaceuticals
• Daiichi Sankyo
• Pharmacosmos
• Sanofi
• Johnson and Johnson
• Fresenius
• ViforPharma
• Rockwell Medical
Iron Deficiency Anemia Therapy Market Insights
Lucintel forecasts that parenteral iron therapy will remain the largest segment over the forecast period due to high demand for patients receiving recombinant erythropoietin therapy or suffering from chronic diseases that hinder iron absorption through oral means.
Within this market, hospital will remain the largest segment as it is equipped to handle complex cases and has necessary facilities and staffs to manage patients.
North America will remain the largest region over the forecast period due to surge in healthcare spending, increasing prevalence of iron deficiency anemia among the population, and the presence of key market players in the region.
Features of the Global Iron Deficiency Anemia Therapy Market
Market Size Estimates: Iron deficiency anemia therapy market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Iron deficiency anemia therapy market size by therapy type, end use, and region in terms of value ($B).
Regional Analysis: Iron deficiency anemia therapy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different therapy types, end uses, and regions for the iron deficiency anemia therapy market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the iron deficiency anemia therapy market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the iron deficiency anemia therapy market size?
Answer: The global iron deficiency anemia therapy market is expected to reach an estimated $4.6 billion by 2030.
Q2. What is the growth forecast for iron deficiency anemia therapy market?
Answer: The global iron deficiency anemia therapy market is expected to grow with a CAGR of 5.3% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the iron deficiency anemia therapy market?
Answer: The major drivers for this market are high incidence of iron deficiency anemia is attributed to insufficient iron intake from food and excessive loss of red blood cells, particularly affecting women and children, surge in female population, and growing awareness towards women health.
Q4. What are the major segments for iron deficiency anemia therapy market?
Answer: The future of the global iron deficiency anemia therapy market looks promising with opportunities in the hospital, clinic, and home healthcare markets.
Q5. Who are the key iron deficiency anemia therapy market companies?
Answer: Some of the key iron deficiency anemia therapy companies are as follows:
• Abbvie
• Akebia Therapeutics
• AMAG Pharmaceuticals
• Daiichi Sankyo
• Pharmacosmos
• Sanofi
• Johnson and Johnson
• Fresenius
• ViforPharma
• Rockwell Medical
Q6. Which iron deficiency anemia therapy market segment will be the largest in future?
Answer: Lucintel forecasts that parenteral iron therapy will remain the largest segment over the forecast period due to high demand for patients receiving recombinant erythropoietin therapy or suffering from chronic diseases that hinder iron absorption through oral means.
Q7. In iron deficiency anemia therapy market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to surge in healthcare spending, increasing prevalence of iron deficiency anemia among the population, and the presence of key market players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the iron deficiency anemia therapy market by therapy type (oral iron therapy, parenteral iron therapy, and red blood cell transfusion), end use (hospitals, clinics, and home healthcare), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Iron Deficiency Anemia Therapy Market, Iron Deficiency Anemia Therapy Market Size, Iron Deficiency Anemia Therapy Market Growth, Iron Deficiency Anemia Therapy Market Analysis, Iron Deficiency Anemia Therapy Market Report, Iron Deficiency Anemia Therapy Market Share, Iron Deficiency Anemia Therapy Market Trends, Iron Deficiency Anemia Therapy Market Forecast, Iron Deficiency Anemia Therapy Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Iron Deficiency Anemia Therapy Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Iron Deficiency Anemia Therapy Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Iron Deficiency Anemia Therapy Market by Therapy Type
3.3.1: Oral Iron Therapy
3.3.2: Parenteral Iron Therapy
3.3.3: Red Blood Cell Transfusion
3.4: Global Iron Deficiency Anemia Therapy Market by End Use
3.4.1: Hospitals
3.4.2: Clinics
3.4.3: Home Healthcare
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Iron Deficiency Anemia Therapy Market by Region
4.2: North American Iron Deficiency Anemia Therapy Market
4.2.2: North American Iron Deficiency Anemia Therapy Market by End Use: Hospitals, Clinics, and Home Healthcare
4.3: European Iron Deficiency Anemia Therapy Market
4.3.1: European Iron Deficiency Anemia Therapy Market by Therapy Type: Oral Iron Therapy, Parenteral Iron Therapy, and Red Blood Cell Transfusion
4.3.2: European Iron Deficiency Anemia Therapy Market by End Use: Hospitals, Clinics, and Home Healthcare
4.4: APAC Iron Deficiency Anemia Therapy Market
4.4.1: APAC Iron Deficiency Anemia Therapy Market by Therapy Type: Oral Iron Therapy, Parenteral Iron Therapy, and Red Blood Cell Transfusion
4.4.2: APAC Iron Deficiency Anemia Therapy Market by End Use: Hospitals, Clinics, and Home Healthcare
4.5: ROW Iron Deficiency Anemia Therapy Market
4.5.1: ROW Iron Deficiency Anemia Therapy Market by Therapy Type: Oral Iron Therapy, Parenteral Iron Therapy, and Red Blood Cell Transfusion
4.5.2: ROW Iron Deficiency Anemia Therapy Market by End Use: Hospitals, Clinics, and Home Healthcare
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Iron Deficiency Anemia Therapy Market by Therapy Type
6.1.2: Growth Opportunities for the Global Iron Deficiency Anemia Therapy Market by End Use
6.1.3: Growth Opportunities for the Global Iron Deficiency Anemia Therapy Market by Region
6.2: Emerging Trends in the Global Iron Deficiency Anemia Therapy Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Iron Deficiency Anemia Therapy Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Iron Deficiency Anemia Therapy Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Abbvie
7.2: Akebia Therapeutics
7.3: AMAG Pharmaceuticals
7.4: Daiichi Sankyo
7.5: Pharmacosmos
7.6: Sanofi
7.7: Johnson and Johnson
7.8: Fresenius
7.9: ViforPharma
7.10: Rockwell Medical
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Iron Deficiency Anemia Therapy Market Report.